Class information for:
Level 1: NEUROMELANIN//AMINOCHROME//DOPAMINE QUINONE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
7381 1373 47.9 76%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
124 3       PARKINSONS DISEASE//MOVEMENT DISORDERS//DEEP BRAIN STIMULATION 67777
332 2             PARKINSONS DISEASE//ALPHA SYNUCLEIN//PARKIN 18089
7381 1                   NEUROMELANIN//AMINOCHROME//DOPAMINE QUINONE 1373

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NEUROMELANIN authKW 909647 7% 45% 90
2 AMINOCHROME authKW 365963 2% 69% 24
3 DOPAMINE QUINONE authKW 261610 1% 59% 20
4 5 S CYSTEINYLDOPAMINE authKW 234886 1% 81% 13
5 CATECHOLAMINE REGULATED PROTEIN authKW 200144 1% 100% 9
6 PARKINSONS DISEASE authKW 197268 38% 2% 516
7 BRUCE R P ORT FAMILY address 180128 1% 90% 9
8 6 HYDROXYDOPAMINE authKW 119857 7% 6% 95
9 DOPAMINOCHROME authKW 111191 0% 100% 5
10 IRON ADMINISTRATION authKW 108963 1% 70% 7

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Neurosciences 11295 53% 0% 721
2 Clinical Neurology 1852 17% 0% 235
3 Biochemistry & Molecular Biology 1364 29% 0% 397
4 Pharmacology & Pharmacy 256 10% 0% 144
5 Biophysics 180 5% 0% 72
6 Toxicology 167 4% 0% 56
7 Geriatrics & Gerontology 103 2% 0% 24
8 Endocrinology & Metabolism 68 4% 0% 55
9 Cell Biology 47 5% 0% 71
10 Chemistry, Medicinal 24 2% 0% 28

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BRUCE R P ORT FAMILY 180128 1% 90% 9
2 BIOMED CNS 88953 0% 100% 4
3 NEUROBIOL DEV BIOL 73672 1% 25% 13
4 NEUROANAT NEUROL EXPT 50035 0% 75% 3
5 CHILD YOUTH PSYCHIAT PSYCHOTHER Y 46324 0% 42% 5
6 PHARMACOLEVE TOPF PARKINSONS FDN 44476 0% 100% 2
7 GRP NEUROQUIM 34740 0% 31% 5
8 RADIOCHEM ACTIVAT ANAL 34740 0% 31% 5
9 IRON BIOL AGING 33354 0% 50% 3
10 MED PROTE BIOANALYT 33354 0% 50% 3

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT 28727 2% 4% 32
2 NEUROTOXICITY RESEARCH 21769 2% 3% 31
3 JOURNAL OF NEURAL TRANSMISSION 11995 3% 1% 47
4 JOURNAL OF NEUROCHEMISTRY 11468 8% 1% 104
5 ADVANCES IN NEUROLOGY 5255 1% 2% 11
6 JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION 4851 1% 3% 7
7 FREE RADICAL BIOLOGY AND MEDICINE 3885 3% 0% 39
8 NEUROCHEMICAL RESEARCH 2890 2% 0% 31
9 NEURODEGENERATION 2136 0% 2% 4
10 NEUROCHEMISTRY INTERNATIONAL 1638 1% 0% 20

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 NEUROMELANIN 909647 7% 45% 90 Search NEUROMELANIN Search NEUROMELANIN
2 AMINOCHROME 365963 2% 69% 24 Search AMINOCHROME Search AMINOCHROME
3 DOPAMINE QUINONE 261610 1% 59% 20 Search DOPAMINE+QUINONE Search DOPAMINE+QUINONE
4 5 S CYSTEINYLDOPAMINE 234886 1% 81% 13 Search 5+S+CYSTEINYLDOPAMINE Search 5+S+CYSTEINYLDOPAMINE
5 CATECHOLAMINE REGULATED PROTEIN 200144 1% 100% 9 Search CATECHOLAMINE+REGULATED+PROTEIN Search CATECHOLAMINE+REGULATED+PROTEIN
6 PARKINSONS DISEASE 197268 38% 2% 516 Search PARKINSONS+DISEASE Search PARKINSONS+DISEASE
7 6 HYDROXYDOPAMINE 119857 7% 6% 95 Search 6+HYDROXYDOPAMINE Search 6+HYDROXYDOPAMINE
8 DOPAMINOCHROME 111191 0% 100% 5 Search DOPAMINOCHROME Search DOPAMINOCHROME
9 IRON ADMINISTRATION 108963 1% 70% 7 Search IRON+ADMINISTRATION Search IRON+ADMINISTRATION
10 CYSTEINYLDOPAMINE 92658 0% 83% 5 Search CYSTEINYLDOPAMINE Search CYSTEINYLDOPAMINE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 SEGURA-AGUILAR, J , PARIS, I , MUNOZ, P , FERRARI, E , ZECCA, L , ZUCCA, FA , (2014) PROTECTIVE AND TOXIC ROLES OF DOPAMINE IN PARKINSON'S DISEASE.JOURNAL OF NEUROCHEMISTRY. VOL. 129. ISSUE 6. P. 898-915 86 56% 36
2 ZUCCA, FA , BASSO, E , CUPAIOLI, FA , FERRARI, E , SULZER, D , CASELLA, L , ZECCA, L , (2014) NEUROMELANIN OF THE HUMAN SUBSTANTIA NIGRA: AN UPDATE.NEUROTOXICITY RESEARCH. VOL. 25. ISSUE 1. P. 13-23 69 66% 22
3 JELLINGER, KA , (1999) THE ROLE OF IRON IN NEURODEGENERATION - PROSPECTS FOR PHARMACOTHERAPY OF PARKINSON'S DISEASE.DRUGS & AGING. VOL. 14. ISSUE 2. P. 115 -140 103 41% 167
4 WAKAMATSU, K , MURASE, T , ZUCCA, FA , ZECCA, L , ITO, S , (2012) BIOSYNTHETIC PATHWAY TO NEUROMELANIN AND ITS AGING PROCESS.PIGMENT CELL & MELANOMA RESEARCH. VOL. 25. ISSUE 6. P. 792-803 49 69% 6
5 STOKES, AH , HASTINGS, TG , VRANA, KE , (1999) CYTOTOXIC AND GENOTOXIC POTENTIAL OF DOPAMINE.JOURNAL OF NEUROSCIENCE RESEARCH. VOL. 55. ISSUE 6. P. 659-665 42 74% 285
6 IZUMI, Y , SAWADA, H , YAMAMOTO, N , KUME, T , KATSUKI, H , SHIMOHAMA, S , AKAIKE, A , (2005) IRON ACCELERATES THE CONVERSION OF DOPAMINE-OXIDIZED INTERMEDIATES INTO MELANIN AND PROVIDES PROTECTION IN SH-SY5Y CELLS.JOURNAL OF NEUROSCIENCE RESEARCH. VOL. 82. ISSUE 1. P. 126-137 39 87% 29
7 ZECCA, L , TAMPELLINI, D , GATTI, A , CRIPPA, R , EISNER, M , SULZER, D , ITO, S , FARIELLO, R , GALLORINI, M , (2002) THE NEUROMELANIN OF HUMAN SUBSTANTIA NIGRA AND ITS INTERACTION WITH METALS.JOURNAL OF NEURAL TRANSMISSION. VOL. 109. ISSUE 5-6. P. 663-672 43 83% 48
8 ZUCCA, FA , GIAVERI, G , GALLORINI, M , ALBERTINI, A , TOSCANI, M , PEZZOLI, G , LUCIUS, R , WILMS, H , SULZER, D , ITO, S , ET AL (2004) THE NEUROMELANIN OF HUMAN SUBSTANTIA NIGRA: PHYSIOLOGICAL AND PATHOGENIC ASPECTS.PIGMENT CELL RESEARCH. VOL. 17. ISSUE 6. P. 610-617 49 64% 77
9 ZECCA, L , ZUCCA, FA , COSTI, P , TAMPELLINI, D , GATTI, A , GERLACH, M , RIEDERER, P , FARIELLO, RG , ITO, S , GALLORINI, M , ET AL (2003) THE NEUROMELANIN OF HUMAN SUBSTANTIA NIGRA: STRUCTURE, SYNTHESIS AND MOLECULAR BEHAVIOUR.JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. VOL. . ISSUE 65. P. 145-155 45 76% 18
10 YOUDIM, MBH , STEPHENSON, G , BEN SHACHAR, D , (2004) IRONING IRON OUT IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES WITH IRON CHELATORS - A LESSON FROM 6-HYDROXYDOPAMINE AND IRON CHELATORS, DESFERAL AND VK-28.REDOX-ACTIVE METALS IN NEUROLOGICAL DISORDERS. VOL. 1012. ISSUE . P. 306-325 46 62% 126

Classes with closest relation at Level 1


Rank Class id link
1 29114 PRAMIPEXOLE//PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE//TALIPEXOLE
2 3681 MPTP//MPP//1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE
3 17747 BIOMOL INTERACT BREMEN//BIOL CHEM 2//GLUTATHIONE
4 29898 3 4 DIHYDROXYPHENYLACETALDEHYDE//3 4 DIHYDROXYPHENYLGLYCOLALDEHYDE//DOPAL
5 24398 ROTENONE//AAV ALPHA SYNUCLEIN//PYRIMIDOTRIAZINEDIONE DERIVATIVES
6 8891 SUSCEPTIBILITY WEIGHTED IMAGING//QUANTITATIVE SUSCEPTIBILITY MAPPING//BRAIN IRON
7 8954 NEUROPHARMACOL SECT//MICROGLIA//PARKINSONS DISEASE
8 5716 EUMELANIN//MELANIN//PHEOMELANIN
9 25950 SKIN BARRIER NETWORK HUMAN OURCES DEV TEAM BK2//LEWY BODY INCLUSION//3 4 5 TRICAFFEOYLQUINIC ACID
10 24756 TRANSCRANIAL SONOGRAPHY//SUBSTANTIA NIGRA HYPERECHOGENICITY//TRANSCRANIAL ULTRASOUND

Go to start page